
by Glaxo SmithKline Pharmaceuticals Ltd
Trelegy Ellipta Powder For Inhalation is used in the treatment of chronic obstructive pulmonary disorder (COPD), a lung disorder in which the flow of air to the lung is blocked. It provides relief from COPD symptoms like wheezing, shortness of breath, coughing, and chest tightness. This medicine is for inhalation purposes only. Thus, it should not be taken by mouth. It is important to follow all the guidelines of the doctor before using it. Before using the medicine, the doctor will guide you on how to use this medicine. Use it in the dose and duration advised by the doctor.Common cold is the most common side effect of this medicine. You may also experience side effects like fungal infection of the mouth, infection of the nose, blocked nose, cough, and headache. If any of these side effects persist or get worse, you should let your doctor know.Do not use this medicine without consulting the doctor if you have any problems related to heart, liver, or if you have glaucoma, tuberculosis (TB), asthma, and enlarged prostate.
Trelegy Ellipta Powder For Inhalation is a combination of fluticasone furoate, umeclidinium, and vilanterol. Fluticasone Furoate works by blocking the production of certain chemicals in the body that cause inflammation (redness and swelling) and allergies. Umeclidinium and vilanterol work by relaxing air passages in the lungs, making breathing easier.
Habit Forming :: No|Therapeutic Class :: RESPIRATORY
Consult a certified doctor for personalised medical advice.